Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells

Daunorubicin is an anticancer drug, and cholesterol is involved in cancer progression, but their relationship has not been defined. In this study, we developed a novel experimental model that utilizes daunorubicin, cholesterol, and daunorubicin plus cholesterol in the same cells (H35) to search for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Codini, Michela, Conte, Carmela, Cataldi, Samuela, Arcuri, Cataldo, Lazzarini, Andrea, Ceccarini, Maria Rachele, Patria, Federica, Floridi, Alessandro, Mecca, Carmen, Ambesi-Impiombato, Francesco Saverio, Beccari, Tommaso, Curcio, Francesco, Albi, Elisabetta
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6274808/
https://ncbi.nlm.nih.gov/pubmed/30388783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19113424
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares